TomoTherapy to present an update on TomoTherapy radiation therapy platform

Oct 12 2009NewsGuard 100/100 Score

TomoTherapy Incorporated (NASDAQ: TOMO) announced today that it will host an analyst and investor presentation in conjunction with the annual ASTRO (American Society for Radiation Oncology) meeting on Monday, Nov. 2, 2009, at 8:00 a.m. CT.

Analysts and institutional investors are invited to register for this event by visiting: http://www.tomotherapy.com/register/2009_astro_analyst_investor_presentation/.

Space is limited and early registration is advised.

TomoTherapy's management team will present an update on its business and highlights of new developments for the TomoTherapy® radiation therapy platform. The company's presentation will be Webcast. To access the live Webcast on Nov. 2, 2009, go to the Investor Relations page of TomoTherapy.com and click on the Webcast icon. A replay of the Webcast will be available beginning at 11:00 a.m. CT on the same day.

Source:

TomoTherapy

Posted in: Device / Technology News

Tags: , , ,

Comments (0)

Suggested Reading

MRI-guided SBRT reduces side effects in prostate cancer treatment
Cetuximab performs better than durvalumab in treating head and neck cancers
New technique offers real-time glioblastoma monitoring
AI model could help clinicians to understand prostate tumor's aggressiveness
AI-powered MRI predicts outcomes in prostate cancer
ASTRO releases updated guidelines for treating locally advanced rectal cancer
Short course chemotherapy boosts survival rates in cervical cancer patients
Jefferson Lab team explores proton therapy as a safer cancer treatment

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Radioprotective effects of Licochalcone B against radiation-induced cell damage